CABIO Biotech (Wuhan) Co. Ltd.SSE: 688089

Announcement on Changing Enterprise Type

Mar 28, 2025 · Issued by CABIO Biotech (Wuhan) Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · Mar 28, 2025

On 6ix: 6ix.com/news/announcement-on-changing-enterprise-type

Announcement on Changing Enterprise Type

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

CABIO Biotech (Wuhan) Co. Ltd. on 6ix

Earlier from CABIO Biotech (Wuhan)

Announcement on Self-Inspection Report on Purchase and Sale of Shares by Relevant Subjects Related to This TransactionMar 21, 2025
Indicative Announcement on Risk of Purchase of Assets and Raising of Supporting Funds through Shares Issuance and Cash Payment and Related TransactionMar 5, 2025
Announcement on Preliminary Earnings Estimate for 2024Feb 28, 2025
Announcement on Adjustment of Core Technical PersonnelFeb 25, 2025
Announcement on Progress in Planning Major Asset RestructuringFeb 11, 2025

Later from CABIO Biotech (Wuhan)

Announcement on Attending 2024 SSE STAR Market Biological Products and CXO Industry Collective Performance BriefingApr 15, 2025
Announcement on Adjusting 2024 Annual Profit Distribution PlanApr 29, 2025
Notice on Convening the 2024 Annual General MeetingMay 9, 2025
Announcement on Changing Major Asset Restructuring Project and Audit Signatory Accountant for 2025May 17, 2025
Announcement on Resolution of the 2024 Annual General MeetingMay 30, 2025

All CABIO Biotech (Wuhan) news releases

Follow CABIO Biotech (Wuhan) into a list and get an email when it puts out news.

Follow CABIO Biotech (Wuhan)